Multi-Institutional experience with FOLFIRINOX in pancreatic adenocarcinoma

Authors

Parvin F. Peddi, Washington University School of Medicine in St. Louis
Sam Lubner, University of Wisconsin - Madison School of MedicineFollow
Robert McWilliams, Mayo Clinic
Benjamin R. Tan, Washington University School of Medicine in St. Louis
Joel Picus, Washington University School of Medicine in St. Louis
Steven M. Sorscher, Washington University School of Medicine in St. Louis
Rama Suresh, Washington University School of Medicine in St. Louis
A Craig Lockhart, Washington University School of Medicine in St. LouisFollow
Jian Wang, The Second Affiliated Hopital of Zhengzhou University
Christine Menias, Washington University School of Medicine in St. Louis
Feng Gao, Washington University School of Medicine in St. LouisFollow
David Linehan, Washington University School of Medicine in St. Louis
Andrea Wang-Gilliam, Washington University School of Medicine in St. Louis

Journal

Journal of the Pancreas

Publication Date

2012

Volume

13

Issue

5

Inclusive Pages

497-501

Document Type

Open Access Publication

DOI

10.6092/1590-8577/913

Rights and Permissions

Parvin F Peddi, et al. Multi-Institutional Experience with FOLFIRINOX in Pancreatic Adenocarcinoma, JOP. J Pancreas (Online) 2012 Sep 10; 13(5):497-501 DOI: 10.6092/1590-8577/913

Recommended Citation

Peddi, Parvin F.; Lubner, Sam; McWilliams, Robert; Tan, Benjamin R.; Picus, Joel; Sorscher, Steven M.; Suresh, Rama; Lockhart, A Craig; Wang, Jian; Menias, Christine; Gao, Feng; Linehan, David; and Wang-Gilliam, Andrea, "Multi-Institutional experience with FOLFIRINOX in pancreatic adenocarcinoma." Journal of the Pancreas. 13, 5. 497-501. (2012).
https://digitalcommons.wustl.edu/open_access_pubs/1283